Fulcrum Therapeutics, Inc. 8-K

Accession 0001193125-21-092672

Filing information

CIK: 0001680581
Report date: 2021-03-23
Filing date: 2021-03-24
Form: 8-K
Primary document: d25784d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.